Jiangsu Nanfang Medical (603880) — Capital Reinvestment Ratio
Jiangsu Nanfang Medical (603880) has a Capital Reinvestment Ratio of 0.18x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥12.53 Million) in capital expenditures (CN¥2.25 Million). Check Jiangsu Nanfang Medical tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Nanfang Medical Capital Reinvestment Ratio (2012–2025)
This chart tracks Jiangsu Nanfang Medical's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see Jiangsu Nanfang Medical (603880) cash flow conversion.
Annual Capital Reinvestment Ratio for Jiangsu Nanfang Medical (2012–2025)
Year-by-year Capital Reinvestment Ratio for Jiangsu Nanfang Medical from 2012 to 2025. See Jiangsu Nanfang Medical free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | CN¥47.73 Million | CN¥13.20 Million | ▼ -46.0% |
| 2024 | 0.51x | CN¥63.32 Million | CN¥32.41 Million | ▼ -88.0% |
| 2023 | 4.27x | CN¥15.51 Million | CN¥66.16 Million | ▼ -8.7% |
| 2022 | 4.67x | CN¥31.28 Million | CN¥146.16 Million | ▲ +484.2% |
| 2020 | 0.80x | CN¥154.12 Million | CN¥123.29 Million | ▼ -53.2% |
| 2019 | 1.71x | CN¥32.99 Million | CN¥56.36 Million | ▲ +15.9% |
| 2018 | 1.47x | CN¥52.75 Million | CN¥77.76 Million | ▲ +133.1% |
| 2017 | 0.63x | CN¥49.24 Million | CN¥31.14 Million | ▲ +16.3% |
| 2016 | 0.54x | CN¥99.35 Million | CN¥54.03 Million | ▲ +11.3% |
| 2015 | 0.49x | CN¥90.66 Million | CN¥44.30 Million | ▲ +417.8% |
| 2014 | 0.09x | CN¥73.52 Million | CN¥6.94 Million | ▼ -93.4% |
| 2013 | 1.43x | CN¥20.14 Million | CN¥28.81 Million | ▲ +409.4% |
| 2012 | 0.28x | CN¥76.07 Million | CN¥21.36 Million | — |